Postoperative Pain Management Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for postoperative pain management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global postoperative pain management market from 2025 to 2032.
Key Insights:
Postoperative pain management involves various therapeutic approaches aimed at alleviating pain following surgical procedures, improving patient recovery, and minimizing complications. The market includes pharmacological treatments such as opioids, non-opioid analgesics, local anesthetics, and novel drug delivery systems, alongside non-pharmacological therapies like nerve blocks and advanced pain management devices. The postoperative pain management market caters to hospitals, ambulatory surgical centers, and homecare settings, offering a range of products and services designed to optimize pain control and enhance patient comfort. Market growth is driven by increasing surgical volumes, rising awareness regarding effective pain management, and innovations in drug formulations and delivery technologies.
Market Growth Drivers:
The global postoperative pain management market is propelled by several key factors, including the increasing number of surgeries worldwide due to aging populations and the rising prevalence of chronic diseases necessitating operative interventions. Growing awareness among healthcare providers and patients about the benefits of effective pain control and enhanced recovery protocols further supports market expansion. Technological advancements, such as the development of targeted drug delivery systems, multimodal analgesia techniques, and minimally invasive pain management devices, contribute to improved treatment outcomes and patient satisfaction. Additionally, the expansion of ambulatory surgery and home-based care models drives demand for convenient and effective pain management solutions.
Market Restraints:
Despite promising growth prospects, the postoperative pain management market faces challenges related to opioid dependency concerns, stringent regulatory policies, and high treatment costs. The opioid crisis has led to increased scrutiny and regulations surrounding opioid prescriptions, limiting their usage and creating demand for alternative pain management therapies. Regulatory hurdles for approval of new analgesics and devices, coupled with reimbursement complexities, pose barriers for market entry and expansion. Furthermore, limited access to advanced pain management options in developing regions restricts market penetration, necessitating strategic efforts to address affordability and accessibility issues.
Market Opportunities:
The postoperative pain management market presents significant growth opportunities driven by innovations in non-opioid analgesics, personalized medicine, and digital health integration. The development of novel analgesic molecules with reduced side effects and dependency risk opens new avenues for safer pain control. Integration of digital platforms for pain monitoring, telemedicine, and patient engagement enhances treatment adherence and outcomes. Moreover, increasing focus on multimodal pain management protocols and enhanced recovery after surgery (ERAS) programs supports broader adoption of comprehensive pain management strategies. Collaborations between pharmaceutical companies, technology providers, and healthcare institutions are crucial to leverage these opportunities and maintain competitive advantage.
Key Questions Answered in the Report:
These companies invest in developing advanced analgesic formulations, non-opioid alternatives, and smart drug delivery systems tailored to diverse patient needs. Collaborations with healthcare providers and research institutions facilitate clinical validation and market access. Emphasis on patient education, safety, and evidence-based protocols fosters market growth and enhances patient outcomes in the evolving postoperative pain management landscape.
Key Companies Profiled:
The postoperative pain management market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various surgical procedures and patient populations.
By Drug
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Postoperative Pain Management Market Size (2025E): USD 45.13 Billion
- Projected Market Value (2032F): USD 65.22 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 5.4%
Postoperative pain management involves various therapeutic approaches aimed at alleviating pain following surgical procedures, improving patient recovery, and minimizing complications. The market includes pharmacological treatments such as opioids, non-opioid analgesics, local anesthetics, and novel drug delivery systems, alongside non-pharmacological therapies like nerve blocks and advanced pain management devices. The postoperative pain management market caters to hospitals, ambulatory surgical centers, and homecare settings, offering a range of products and services designed to optimize pain control and enhance patient comfort. Market growth is driven by increasing surgical volumes, rising awareness regarding effective pain management, and innovations in drug formulations and delivery technologies.
Market Growth Drivers:
The global postoperative pain management market is propelled by several key factors, including the increasing number of surgeries worldwide due to aging populations and the rising prevalence of chronic diseases necessitating operative interventions. Growing awareness among healthcare providers and patients about the benefits of effective pain control and enhanced recovery protocols further supports market expansion. Technological advancements, such as the development of targeted drug delivery systems, multimodal analgesia techniques, and minimally invasive pain management devices, contribute to improved treatment outcomes and patient satisfaction. Additionally, the expansion of ambulatory surgery and home-based care models drives demand for convenient and effective pain management solutions.
Market Restraints:
Despite promising growth prospects, the postoperative pain management market faces challenges related to opioid dependency concerns, stringent regulatory policies, and high treatment costs. The opioid crisis has led to increased scrutiny and regulations surrounding opioid prescriptions, limiting their usage and creating demand for alternative pain management therapies. Regulatory hurdles for approval of new analgesics and devices, coupled with reimbursement complexities, pose barriers for market entry and expansion. Furthermore, limited access to advanced pain management options in developing regions restricts market penetration, necessitating strategic efforts to address affordability and accessibility issues.
Market Opportunities:
The postoperative pain management market presents significant growth opportunities driven by innovations in non-opioid analgesics, personalized medicine, and digital health integration. The development of novel analgesic molecules with reduced side effects and dependency risk opens new avenues for safer pain control. Integration of digital platforms for pain monitoring, telemedicine, and patient engagement enhances treatment adherence and outcomes. Moreover, increasing focus on multimodal pain management protocols and enhanced recovery after surgery (ERAS) programs supports broader adoption of comprehensive pain management strategies. Collaborations between pharmaceutical companies, technology providers, and healthcare institutions are crucial to leverage these opportunities and maintain competitive advantage.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the postoperative pain management market globally?
- Which types of analgesics and pain management techniques are gaining prominence across various healthcare settings?
- How are technological advancements influencing treatment protocols and patient outcomes in postoperative pain management?
- Who are the key players contributing to the postoperative pain management market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global postoperative pain management market?
These companies invest in developing advanced analgesic formulations, non-opioid alternatives, and smart drug delivery systems tailored to diverse patient needs. Collaborations with healthcare providers and research institutions facilitate clinical validation and market access. Emphasis on patient education, safety, and evidence-based protocols fosters market growth and enhances patient outcomes in the evolving postoperative pain management landscape.
Key Companies Profiled:
- Teva Pharmaceutical Industries Ltd
- Novartis AG
- Allergan plc
- GlaxoSmithKline plc
- Mylan N.V.
- Johnson & Johnson
- Pfizer Inc.
- Purdue Pharma L.P
- Janssen Pharmaceuticals, Inc
- Endo International plc
- Baxter International
- Pacira Pharmaceuticals Inc.
- Cadila Healthcare Limited
- Cipla Limited
- Eisan
- LG Chem
- AbbVie Inc.
- Amgen Inc.
- Sun Pharmaceutical Ltd.
The postoperative pain management market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various surgical procedures and patient populations.
By Drug
- Opioids
- Tramadol
- Oxycodone
- Hydrocodone
- Other Opioids
- NSAIDs
- Local Anesthetics
- Acetaminophen
- Injectable
- Oral
- Rectal
- Topical
- Transdermal
- Others
- Over-the-counter (OTC) Products
- Prescription Drugs
- Hospital Pharmacies
- Specialty Clinics
- Long Term Care Centers
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
193 Pages
- 1. Executive Summary
- 1.1. Global Postoperative Pain Management Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors – Relevance and Impact
- 3. Value Added Insights
- 3.1. Regulatory Landscape
- 3.2. Product Adoption Analysis
- 3.3. Value Chain Analysis
- 3.4. Key Deals and Mergers
- 3.5. PESTLE Analysis
- 3.6. Porter’s Five Force Analysis
- 4. Global Postoperative Pain Management Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025–2032
- 4.3. Global Postoperative Pain Management Market Outlook: Drug
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Drug, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 4.3.3.1. Opioids
- 4.3.3.1.1. Tramadol
- 4.3.3.1.2. Oxycodone
- 4.3.3.1.3. Hydrocodone
- 4.3.3.1.4. Other Opioids
- 4.3.3.2. NSAIDs
- 4.3.3.3. Local Anesthetics
- 4.3.3.4. Acetaminophen
- 4.3.4. Market Attractiveness Analysis: Drug
- 4.4. Global Postoperative Pain Management Market Outlook: Route of Administration
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 4.4.3.1. Injectable
- 4.4.3.2. Oral
- 4.4.3.3. Rectal
- 4.4.3.4. Topical
- 4.4.3.5. Transdermal
- 4.4.3.6. Others
- 4.4.4. Market Attractiveness Analysis: Route of Administration
- 4.5. Global Postoperative Pain Management Market Outlook: Prescription Type
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Type, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 4.5.3.1. Over-The-Counter (OTC) Products
- 4.5.3.2. Prescription Drugs
- 4.5.4. Market Attractiveness Analysis: Prescription Type
- 4.6. Global Postoperative Pain Management Market Outlook: Distribution Channel
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
- 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 4.6.3.1. Hospital Pharmacies
- 4.6.3.2. Specialty Clinics
- 4.6.3.3. Long Term Care Centers
- 4.6.3.4. Retail Pharmacies
- 4.6.3.5. Drug Stores
- 4.6.3.6. Online Pharmacies
- 4.6.4. Market Attractiveness Analysis: Distribution Channel
- 5. Global Postoperative Pain Management Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
- 6. North America Postoperative Pain Management Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Drug
- 6.2.3. By Route of Administration
- 6.2.4. By Prescription Type
- 6.2.5. By Distribution Channel
- 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 6.4.1. Opioids
- 6.4.1.1. Tramadol
- 6.4.1.2. Oxycodone
- 6.4.1.3. Hydrocodone
- 6.4.1.4. Other Opioids
- 6.4.2. NSAIDs
- 6.4.3. Local Anesthetics
- 6.4.4. Acetaminophen
- 6.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 6.5.1. Injectable
- 6.5.2. Oral
- 6.5.3. Rectal
- 6.5.4. Topical
- 6.5.5. Transdermal
- 6.5.6. Others
- 6.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 6.6.1. Over-The-Counter (OTC) Products
- 6.6.2. Prescription Drugs
- 6.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 6.7.1. Hospital Pharmacies
- 6.7.2. Specialty Clinics
- 6.7.3. Long Term Care Centers
- 6.7.4. Retail Pharmacies
- 6.7.5. Drug Stores
- 6.7.6. Online Pharmacies
- 6.8. Market Attractiveness Analysis
- 7. Europe Postoperative Pain Management Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Drug
- 7.2.3. By Route of Administration
- 7.2.4. By Prescription Type
- 7.2.5. By Distribution Channel
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Rest of Europe
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 7.4.1. Opioids
- 7.4.1.1. Tramadol
- 7.4.1.2. Oxycodone
- 7.4.1.3. Hydrocodone
- 7.4.1.4. Other Opioids
- 7.4.2. NSAIDs
- 7.4.3. Local Anesthetics
- 7.4.4. Acetaminophen
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 7.5.1. Injectable
- 7.5.2. Oral
- 7.5.3. Rectal
- 7.5.4. Topical
- 7.5.5. Transdermal
- 7.5.6. Others
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 7.6.1. Over-The-Counter (OTC) Products
- 7.6.2. Prescription Drugs
- 7.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 7.7.1. Hospital Pharmacies
- 7.7.2. Specialty Clinics
- 7.7.3. Long Term Care Centers
- 7.7.4. Retail Pharmacies
- 7.7.5. Drug Stores
- 7.7.6. Online Pharmacies
- 7.8. Market Attractiveness Analysis
- 8. East Asia Postoperative Pain Management Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Drug
- 8.2.3. By Route of Administration
- 8.2.4. By Prescription Type
- 8.2.5. By Distribution Channel
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 8.4.1. Opioids
- 8.4.1.1. Tramadol
- 8.4.1.2. Oxycodone
- 8.4.1.3. Hydrocodone
- 8.4.1.4. Other Opioids
- 8.4.2. NSAIDs
- 8.4.3. Local Anesthetics
- 8.4.4. Acetaminophen
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 8.5.1. Injectable
- 8.5.2. Oral
- 8.5.3. Rectal
- 8.5.4. Topical
- 8.5.5. Transdermal
- 8.5.6. Others
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 8.6.1. Over-The-Counter (OTC) Products
- 8.6.2. Prescription Drugs
- 8.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 8.7.1. Hospital Pharmacies
- 8.7.2. Specialty Clinics
- 8.7.3. Long Term Care Centers
- 8.7.4. Retail Pharmacies
- 8.7.5. Drug Stores
- 8.7.6. Online Pharmacies
- 8.8. Market Attractiveness Analysis
- 9. South Asia & Oceania Postoperative Pain Management Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Drug
- 9.2.3. By Route of Administration
- 9.2.4. By Prescription Type
- 9.2.5. By Distribution Channel
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 9.4.1. Opioids
- 9.4.1.1. Tramadol
- 9.4.1.2. Oxycodone
- 9.4.1.3. Hydrocodone
- 9.4.1.4. Other Opioids
- 9.4.2. NSAIDs
- 9.4.3. Local Anesthetics
- 9.4.4. Acetaminophen
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 9.5.1. Injectable
- 9.5.2. Oral
- 9.5.3. Rectal
- 9.5.4. Topical
- 9.5.5. Transdermal
- 9.5.6. Others
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 9.6.1. Over-The-Counter (OTC) Products
- 9.6.2. Prescription Drugs
- 9.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 9.7.1. Hospital Pharmacies
- 9.7.2. Specialty Clinics
- 9.7.3. Long Term Care Centers
- 9.7.4. Retail Pharmacies
- 9.7.5. Drug Stores
- 9.7.6. Online Pharmacies
- 9.8. Market Attractiveness Analysis
- 10. Latin America Postoperative Pain Management Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Drug
- 10.2.3. By Route of Administration
- 10.2.4. By Prescription Type
- 10.2.5. By Distribution Channel
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 10.4.1. Opioids
- 10.4.1.1. Tramadol
- 10.4.1.2. Oxycodone
- 10.4.1.3. Hydrocodone
- 10.4.1.4. Other Opioids
- 10.4.2. NSAIDs
- 10.4.3. Local Anesthetics
- 10.4.4. Acetaminophen
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 10.5.1. Injectable
- 10.5.2. Oral
- 10.5.3. Rectal
- 10.5.4. Topical
- 10.5.5. Transdermal
- 10.5.6. Others
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 10.6.1. Over-The-Counter (OTC) Products
- 10.6.2. Prescription Drugs
- 10.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 10.7.1. Hospital Pharmacies
- 10.7.2. Specialty Clinics
- 10.7.3. Long Term Care Centers
- 10.7.4. Retail Pharmacies
- 10.7.5. Drug Stores
- 10.7.6. Online Pharmacies
- 10.8. Market Attractiveness Analysis
- 11. Middle East & Africa Postoperative Pain Management Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Drug
- 11.2.3. By Route of Administration
- 11.2.4. By Prescription Type
- 11.2.5. By Distribution Channel
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
- 11.4.1. Opioids
- 11.4.1.1. Tramadol
- 11.4.1.2. Oxycodone
- 11.4.1.3. Hydrocodone
- 11.4.1.4. Other Opioids
- 11.4.2. NSAIDs
- 11.4.3. Local Anesthetics
- 11.4.4. Acetaminophen
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
- 11.5.1. Injectable
- 11.5.2. Oral
- 11.5.3. Rectal
- 11.5.4. Topical
- 11.5.5. Transdermal
- 11.5.6. Others
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
- 11.6.1. Over-The-Counter (OTC) Products
- 11.6.2. Prescription Drugs
- 11.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 11.7.1. Hospital Pharmacies
- 11.7.2. Specialty Clinics
- 11.7.3. Long Term Care Centers
- 11.7.4. Retail Pharmacies
- 11.7.5. Drug Stores
- 11.7.6. Online Pharmacies
- 11.8. Market Attractiveness Analysis
- 12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Teva Pharmaceutical Industries Ltd
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Novartis AG
- 12.3.3. Allergan plc
- 12.3.4. GlaxoSmithKline plc
- 12.3.5. Mylan N.V.
- 12.3.6. Johnson & Johnson
- 12.3.7. Pfizer Inc.
- 12.3.8. Purdue Pharma L.P
- 12.3.9. Janssen Pharmaceuticals, Inc
- 12.3.10. Endo International plc
- 12.3.11. Baxter International
- 12.3.12. Pacira Pharmaceuticals Inc.
- 12.3.13. Cadila Healthcare Limited
- 12.3.14. Cipla Limited
- 12.3.15. Eisan
- 12.3.16. LG Chem
- 12.3.17. AbbVie Inc.
- 12.3.18. Amgen Inc.
- 12.3.19. Sun Pharmaceutical Ltd.
- 13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
